Marion McCourt
At a glance: Marion McCourt is Evp Commercial at Regeneron Pharmaceuticals (REGN). Their latest SEC Form 4, filed Nov 18, 2026, reported a sale of $42K. On file: 0 purchase lines ($0) and 16 sale lines ($3.5M).
Disclosed holdings: about $9.6M of REGN stock: 10,305 shares reported on their latest Form 4 (filed Nov 18, 2026), valued at the Nov 19, 2026 close of $932.53. This counts only REGN shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Evp Commercial at Regeneron Pharmaceuticals, Inc. (REGN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Marion McCourt's InsiderPrint
16 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 16 times a year, typically $47K a trade; most sales are on a pre-planned 10b5-1 schedule; trades in the same month most years.
- Bump outward: a purchase (0)
- Dent inward: a sale (16)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Jack W. CallicuttCFO · GALT · 100% match
- Carole HuntsmanChief Commercial Officer · MDGL · 100% match
- Kim R. TsuchimotoDirector · MNPR · 99% match
- Craig GraceyChief Accounting Officer · OMDA · 99% match
- Justin KrauseSvp Finance And Controller · SEZL · 99% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 18SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 4410,827 held (−0%) | $952.79 | $42K | -2.1% |
| Nov 18SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 5910,768 held (−1%) | $954.46 | $56K | -2.3% |
| Nov 18SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 3010,738 held (−0%) | $955.51 | $29K | -2.4% |
| Nov 18SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 2210,716 held (−0%) | $956.01 | $21K | -2.5% |
| Nov 18SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 4410,672 held (−0%) | $958.47 | $42K | -2.7% |
| Nov 18SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 6610,606 held (−1%) | $959.46 | $63K | -2.8% |
| Nov 18SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 4910,557 held (−0%) | $960.31 | $47K | -2.9% |
| Nov 18SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 5910,498 held (−1%) | $961.36 | $57K | -3.0% |
| Nov 18SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 4110,457 held (−0%) | $962.44 | $39K | -3.1% |
| Nov 18SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 4210,415 held (−0%) | $963.70 | $40K | -3.2% |
| Nov 18SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 2110,394 held (−0%) | $964.69 | $20K | -3.3% |
| Nov 18SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 6310,331 held (−1%) | $965.62 | $61K | -3.4% |
| Nov 18SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 2610,305 held (−0%) | $971.93 | $25K | -4.1% |
| Nov 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1,13210,871 held (−9%) | $869.43 | $984K | +7.3% |
| Sep 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1,21513,134 held (−8%) | $850.00 | $1.0M | +9.7% |
| Sep 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1,13112,003 held (−9%) | $857.39 | $970K | +8.8% |
- Sell
Evp Commercial Marion Mccourt sold $42K of REGN at $952.79 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp Commercial Marion Mccourt sold $56K of REGN at $954.46 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp Commercial Marion Mccourt sold $29K of REGN at $955.51 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp Commercial Marion Mccourt sold $21K of REGN at $956.01 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp Commercial Marion Mccourt sold $42K of REGN at $958.47 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp Commercial Marion Mccourt sold $63K of REGN at $959.46 — pre-scheduled 10b5-1 plan sale.
Follow Marion McCourt
Get one email when Marion McCourt files a new purchase or sale. Free.
At most one email a day about Marion McCourt, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.